Skip to content
To the full analysis

Cronos Group stock: growth

CRON
$3.41Closing price of 12 Nov 2026MEQIRI Score 61 out of 100

Cronos Group reported $149.15M in revenue for fiscal 2025, up 26.8% on the prior year, up 29.3% a year on average over up to five years.

Daily figure as of 13 Nov 2026

Revenue (Annual rate)
no data
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data

Growth per year by period

What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.

since 2020since 2015since 2012
Revenue26.1%45.9%no data
Revenue per share23.8%15.9%no data
Earningsno datano datano data
Earnings per shareno datano datano data
Free cash flowno datano datano data
Free cash flow per shareno datano datano data

Fiscal years at a glance

How revenue and earnings grow

  • Revenue
  • Earnings
  • Free cash flow
Figures as a table
YearRevenueEarningsFree cash flow
2012$0−$31.16K$0
2014−$665K−$4.15M−$2.39M
2015$3.41M$278.28K−$2.08M
2016$412.32K−$1.2M−$5.95M
2017$4.14M$2.53M−$38.37M
2018$12.12M−$21.64M−$91.41M
2019$17.84M$1.19B−$126.9M
2020$46.72M−$73.14M−$180.26M
2021$64.56M−$396.11M−$165.88M
2022$86.75M−$168.73M−$93.98M
2023$87.24M−$73.96M−$46.26M
2024$117.62M$41.08M$5.69M
2025$149.15M−$9.61M$151.61K

Revenue by segment

How Cronos Group Inc. makes its money and how that has shifted. Names are as the company reports them.

  • Cannabis Flower73%
  • Cannabis Extracts25%
  • Other2%

“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.

Figures as a table
202320242025Share 2025
Cannabis Flower$62.07M$87.91M$108.48M72.7%
Cannabis Extracts$24.57M$29.17M$37.7M25.3%
Other$0$0$2.98M2%
Total revenue$87.24M$117.62M$149.15M100%

Revenue by region

Where Cronos Group Inc. generates its revenue.

  • Canada61%
  • Israel28%
  • Other11%

“Other” combines smaller regions with revenue the company does not assign to a region.

Figures as a table
202320242025Share 2025
Canada$64.7M$82.44M$90.33M60.6%
Israel$21.13M$28.37M$41.8M28%
Other$1.41M$6.81M$17.03M11.4%
Total revenue$87.24M$117.62M$149.15M100%

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 7 Aug 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy